Well known and widely used in the vaccine industry, Pel-Freez enables a range of safety and efficacy assays including:
- Complement-dependent cytotoxicity assays (CDC)
- Opsonophagocytic killing assays (OPKA)
- Serum bactericidal assays (SBA)
With the ability to deliver bulk scales of consistently-performing human complement >99% depleted of background killing antibodies through our proprietary process, we can spare your teams the hassle of preparing your own complement, maximizing efficiency and productivity.
Assay Development & Validation
In addition to advancing vaccine development, Pel-Freez’s human blood products for research can support development and validation of a range of assays. You’ll find serum and plasma from healthy donors—available as pooled or individual donor samples—for fueling the development and validation of assays that analyze human blood.
And with ready-to-use complement, antibody-depleted serum, and immunoglobulins, you’ve got reliable components for vaccine safety and efficacy assays and more.
In Vitro Diagnostics (IVDs)
Our human blood products can also support development of IVDs that test for or rely on plasma, serum, or immune components. All serum and plasma is ethically obtained, fully consented and collected under IRB approved protocols, and ready for use in your IVD development program.
All other human blood products start with the same ethically collected serum and plasma and are further processed in our facility using tightly controlled and highly standardized workflows. As a result, you can be confident that the consistency, quality, and reliability of our materials can be counted on to advance your IVD program.